Meet Our Experts
Please select a topic:
Experts for: Clinical Development Phase I
Christian Hucke
- Clinical and non-clinical Project Management
- Interim Management, Strategy
- Clinical Operations, Clinical Study Management
- Quality Risk Management
Alexander Krannich
Dr. Alexander Krannich provides expert biostatistics and clinical study support services for pharmaceutical, medical device, biotech and digital health (DiGA) clients. He handles study planning, statistical analysis, and reporting to meet regulatory requirements (e.g., EMA, FDA, BfArM). Their services include study design, sample size calculation, endpoint definition, data analysis, and support throughout the entire clinical research process. They also offer Real-World Evidence analysis and training through the BioStats Academy.
Daniel Sehrt
Expert for Early Clinical Research & Development
- Scientific concept & design of Phase I-IIa trials
- Clinical pharmacology (PK/PD and pharmacogenomics)
- Clinical trial applications
Sabine Pilari
Expert for Pharmacometrics and PK/PD Modeling
- PK and PK/PD analyses, including exposure-response, mechanistic, and PBPK modeling
- Human PK prediction and estimation of efficacious & starting doses
- Pharmacometrics analysis, population PK, and PK/PD modeling
- Guidance on dose selection and dosing regimen optimization for clinical studies
Jörg Täubel
Expert for cardiac safety in drug development
Frank S. Zollmann
Expert for Pre-/ Clinical Drug Development
- Safety pharmacology, toxicology, pharmacogenomics
- Integrated preclinical & clinical development up to PoC
- Clinical pharmacology